Eli Lilly Sues Six Companies Over Alleged Illegal Sales of Experimental Obesity Drug Retatrutide

3-line summary

• Eli Lilly filed lawsuits against six companies over alleged illegal sales of its experimental obesity drug retatrutide, which has not yet received regulatory approval, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.